Terms: = Uterine cancer AND KDM6A, O15550, UTX, 7403, ENSG00000147050, DKFZp686A03225, RP13-886N14_3, MGC141941, bA386N14_2 AND Prognosis
4666 results:
1. N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma.
Tian Q; Huang J; Zhang Q; Zhao J
Clin Exp Pharmacol Physiol; 2024 Jun; 51(6):e13864. PubMed ID: 38679464
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Significance of Serum SCC Levels Before Treatment for Locally Advanced Cervical Squamous Cell Carcinoma.
Yamaoka Y; Tamura S; Yamanoi K; Taki M; Murakami R; Yamaguchi K; Hamanishi J; Mandai M
Anticancer Res; 2024 May; 44(5):2009-2019. PubMed ID: 38677756
[TBL] [Abstract] [Full Text] [Related]
3. Prevalence of high-risk human papillomavirus infection among women with diabetes mellitus in Accra, Ghana.
Atiase Y; Effah K; Mawusi Wormenor C; Tekpor E; Aku Catherine Morkli E; Boafo E; Yorke E; Aryee R; Essel NOM; Danyo S; Kemawor S; Akpalu J
BMC Womens Health; 2024 Apr; 24(1):260. PubMed ID: 38664791
[TBL] [Abstract] [Full Text] [Related]
4. [
Adam JA; Poel E; van Eck Smit BLF; Mom CH; Stalpers LJA; Laan JJ; Kidd E; Stoker J; Bipat S
BMC Cancer; 2024 Apr; 24(1):513. PubMed ID: 38654241
[TBL] [Abstract] [Full Text] [Related]
5. [Establishment of a prognostic nomogram and discussion on optimal treatment for cervical adenocarcinoma:a retrospective study based on SEER database and Chinese single-center data].
Li X; Gao YH; Yang Z; Ma Y; Liu C; Liu GC; Wang DB
Zhonghua Fu Chan Ke Za Zhi; 2024 Apr; 59(4):307-319. PubMed ID: 38644277
[No Abstract] [Full Text] [Related]
6. Sarcoma of the uterine cervix: experience of a single center.
Yuan H; Li L; Li N; Yao H
World J Surg Oncol; 2024 Apr; 22(1):104. PubMed ID: 38637834
[TBL] [Abstract] [Full Text] [Related]
7. FOXO3a deregulation in uterine smooth muscle tumors.
de Almeida TG; Ricci AR; Dos Anjos LG; Soares Junior JM; Maciel GAR; Baracat EC; Carvalho KC
Clinics (Sao Paulo); 2024; 79():100350. PubMed ID: 38636197
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic and therapeutic potential of STAT3: Opportunities and challenges in targeting HPV-mediated cervical carcinogenesis.
Janjua D; Thakur K; Aggarwal N; Chaudhary A; Yadav J; Chhokar A; Tripathi T; Joshi U; Senrung A; Bharti AC
Crit Rev Oncol Hematol; 2024 May; 197():104346. PubMed ID: 38608913
[TBL] [Abstract] [Full Text] [Related]
9. The differential expression of AFF3 in cervical cancer and its correlation with clinicopathological features and prognosis.
Zhang Y; Li L; Han Q; Wen L
J Obstet Gynaecol; 2024 Dec; 44(1):2333784. PubMed ID: 38602239
[TBL] [Abstract] [Full Text] [Related]
10. Construction of artificial neural network (ANN) based on predictive value of prognostic nutritional index (PNI) and neutrophil-to-lymphocyte ratio (NLR) in patients with cervical squamous cell carcinoma.
Li X; Ou C; He A
Medicine (Baltimore); 2024 Apr; 103(14):e37680. PubMed ID: 38579053
[TBL] [Abstract] [Full Text] [Related]
11. Risk assessment of extra-uterine involvement and prognosis in young type I endometrial carcinoma with high or moderate differentiation and less than 1/2 myometrial invasion.
Sun Y; Han P; Wang Y; Cheng X; Wu W; Liu Q; Ren F
Aging (Albany NY); 2024 Apr; 16(7):6445-6454. PubMed ID: 38575312
[TBL] [Abstract] [Full Text] [Related]
12. Development and validation of prognostic nomographs for patients with cervical cancer: SEER-based Asian population study.
Zeng S; Yang P; Xiao S; Liu L
Sci Rep; 2024 Apr; 14(1):7681. PubMed ID: 38561337
[TBL] [Abstract] [Full Text] [Related]
13. A retrospective study of the effects of uterine manipulators on prognosis in patients with cervical cancer.
Guo X; Zhao E; Guan Z; Li W; Zhang J; Tian S; Yao Y
J Int Med Res; 2024 Mar; 52(3):3000605241233966. PubMed ID: 38553028
[TBL] [Abstract] [Full Text] [Related]
14. STING agonist inflames the cervical cancer immune microenvironment and overcomes anti-PD-1 therapy resistance.
Li T; Zhang W; Niu M; Wu Y; Deng X; Zhou J
Front Immunol; 2024; 15():1342647. PubMed ID: 38550593
[TBL] [Abstract] [Full Text] [Related]
15. The Prognostic and Immune Significance of BZW2 in Pan-cancer and its Relationship with Proliferation and Apoptosis of Cervical cancer.
Li C; Li Q; Li L; Sun S; Lei X
Front Biosci (Landmark Ed); 2024 Mar; 29(3):97. PubMed ID: 38538258
[TBL] [Abstract] [Full Text] [Related]
16. Roles of Matrix Metalloproteinases 2 and 9 in uterine Leiomyosarcoma.
Wang X; Li C; Lou L; Zhu H
Anticancer Res; 2024 Apr; 44(4):1465-1473. PubMed ID: 38537953
[TBL] [Abstract] [Full Text] [Related]
17. The interplay between HPV, other Sexually Transmissible Infections and genital microbiome on cervical microenvironment (MicroCervixHPV study).
Gonçalves-Nobre JG; Matos A; Carreira M; Santos AC; Veiga LC; Ginete C; Brito M; Pires M; Pereira H; Cardoso C; Bicho M; Bicho MC
Front Cell Infect Microbiol; 2023; 13():1251913. PubMed ID: 38532749
[TBL] [Abstract] [Full Text] [Related]
18. Association of tet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance.
Kuang L; Zhang J; Li Y; Wang Q; Liu J; Zhang B
BMC Womens Health; 2024 Mar; 24(1):188. PubMed ID: 38515066
[TBL] [Abstract] [Full Text] [Related]
19. The analysis of preoperative or intraoperative factors in predicting the escalation of surgical pathological staging of patients with clinical stage I endometrioid carcinoma: A retrospective clinical study.
Li N; Chen Q; Li B
Medicine (Baltimore); 2024 Mar; 103(11):e37465. PubMed ID: 38489719
[TBL] [Abstract] [Full Text] [Related]
20. Prognostic evaluation of lymph-vascular space invasion in patients with endometrioid and non-endometrioid endometrial cancer: A multicenter study.
Feng J; Zhang Y; Huang C; Li L; Liu J; Wang J; Guo H; Yao S; Cui Z; Chen G; Gao Q; Sun C; Ma D; Wang B; Li Y; Chu R; Kong B
Eur J Surg Oncol; 2024 Apr; 50(4):108261. PubMed ID: 38484494
[TBL] [Abstract] [Full Text] [Related]
[Next]
